Audiological ototoxicity monitoring guidelines: a review of current evidence and appraisal of quality using the AGREE II tool-Reference-Cited by-同舟云学术

Audiological ototoxicity monitoring guidelines: a review of current evidence and appraisal of quality using the AGREE II tool

Published:2023-12-07 Issue: Volume: Page:1-6
ISSN:1499-2027
Container-title:International Journal of Audiology
language:en
Short-container-title:International Journal of Audiology

Author:

Lester Georgia M.¹^ORCID,Wilson Wayne J.¹^ORCID,Timmer Barbra H. B.¹²^ORCID,Ladwa Rahul M.³⁴^ORCID

Affiliation:

1. School of Health and Rehabilitation Sciences, The University of Queensland, Brisbane, Australia

2. Sonova AG, Staefa, Switzerland

3. Princess Alexandra Hospital, Metro South Hospital and Health Service, Queensland Health, Brisbane, Australia

4. Faculty of Medicine, The University of Queensland, Brisbane, Australia

Publisher

Informa UK Limited

Subject

Speech and Hearing,Linguistics and Language,Language and Linguistics

Link

https://www.tandfonline.com/doi/pdf/10.1080/14992027.2023.2278018

Reference52 articles.

1. Agree Collaboration. 2009. “Appraisal of Guidelines for Research and Evaluation in Europe ǁ (AGREE ǁ) Instrument.” Accessed May 12 2019. http://www.agreetrust.org/

2. American Academy of Audiology. 2009. “Position Statement and Clinical Practice Guidelines: Ototoxicity Monitoring.” https://audiology-web.s3.amazonaws.com/migrated/OtoMonGuidelines.pdf_539974c40999c1.58842217.pdf

3. American Speech-Language Hearing Association. 1994. “Audiologic Management of Individuals Receiving Cochleotoxic Drug Therapy.” https://www.asha.org/policy/gl1994-00003/

4. AGREE II appraisals of clinical practice guidelines in rehabilitation showed poor reporting and moderate variability in quality ratings when users apply different cuff-offs: a methodological study

5. Association of Hearing Loss With Psychological Distress and Utilization of Mental Health Services Among Adults in the United States